Loading...
01/11 16:20
Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call reveals a mixed but generally positive outlook. Financial performance is stable with strong cash flow and debt reduction, despite slight revenue decline and margin pressure. Optimistic guidance for Q2 and beyond, along with strategic customer commitments, suggests future growth. Share repurchase and debt reduction enhance shareholder value. The Q&A indicates potential market share gains and improved margins. Tariff impacts are minimal, and customer demand remains solid. Overall, these factors suggest a potential positive stock price movement over the next two weeks.
Revenue $132 million, down 1% year-over-year; at the high end of the guided range.
EPS $0.18, flat year-over-year; at the midpoint of the guided range.
Medtech and Specialty Audio Revenue $60 million, up slightly year-over-year; seasonally down from Q4.
Precision Device Revenue $73 million, down 2% year-over-year; expected due to production challenges.
Gross Margins 48.7%, down 450 basis points year-over-year; impacted by supply agreement with Syntient and unfavorable customer mix.
SG&A Expenses $25 million, down $2 million year-over-year; driven by cost reduction actions.
Interest Expense $3 million, down $2 million year-over-year; due to reduced debt level.
Cash from Operations $1 million, exceeding the high end of the guided range; driven by higher than expected customer prepayments.
Capital Spending $4 million; reflects ongoing investments.
Debt Reduction $15 million; reflects strong cash generation.
Cash Balance $102 million; reflects strong cash generation.
Net Leverage Ratio 0.7 times; indicates manageable debt levels.
Liquidity Excess of $350 million; includes cash on hand and unused capacity under revolving credit facility.
New Product Developments: We continue to see strong design wins across our product portfolio, particularly in medtech, defense, and EV markets with our ceramic capacitors.
Market Expansion: Our backlog for the medtech and specialty audio segment for Q2 is strong, indicating continued innovative solutions and enhancing performance in these markets.
Booking Trends: Q1 booking trends for the Precision Device segment were strong for the second consecutive quarter, with broad-based strength across most end markets.
Operational Efficiencies: We are making progress in our specialty film line production, with a new prototype production line improving production flow and yields.
Cash Generation: We generated $1 million in cash from operating activities, exceeding the high end of our guided range.
Strategic Shifts: We expect to explore acquisition opportunities, buy back shares, and maintain manageable debt levels as we generate robust cash from operations throughout 2025.
Tariff Exposure: Knowles Corporation faces direct tariff exposure, with less than 5% of revenue potentially subject to tariffs. The company believes it can pass these costs onto customers without significant loss of business.
Indirect Tariff Impact: The company estimates that less than 3% of its cost of goods sold will be affected by tariffs, and anticipates recovering most of these costs through price increases.
Customer Demand Impact: The impact of tariffs on customer demand is uncertain. However, Knowles believes that its markets in medtech, defense, and industrial sectors will be relatively insulated from these impacts.
Production Challenges: Knowles is experiencing production challenges in its specialty film line, which could affect revenue growth in the Precision Device segment.
Economic Sensitivity: The industrial market is more sensitive to economic downturns, and while there is currently no impact on demand, the company is closely monitoring the macroeconomic environment.
Gross Margin Decline: Gross margins have declined due to unfavorable customer mix and a supply agreement with Syntient, which negatively impacted margins by nearly 200 basis points.
Proximity Manufacturing Strategy: Less than 5% of revenue is subject to current tariffs due to proximity manufacturing, allowing for potential recovery of tariff impacts through price increases.
Growth in Medtech and Specialty Audio: Expectations of year-over-year revenue growth accelerating in Q2 2025, driven by strong backlog and innovative solutions.
Precision Device Segment: Strong design and quoting activity in medtech, defense, and EV markets, with expectations of year-over-year growth returning in Q2 2025.
Share Repurchase and Debt Reduction: In Q1, $5 million in shares were repurchased and $15 million in debt was reduced, with plans for continued cash generation and potential acquisitions.
Investor Day: Scheduled for May 13, 2025, to discuss future growth plans and competitive advantages.
Q2 Revenue Guidance: Expected revenue between $135 million and $145 million.
Q2 EPS Guidance: Projected EPS range of $0.21 to $0.25 per share.
Q2 EBIT Margin Guidance: Adjusted EBIT margin projected between 19% to 21%.
Full-Year Capital Spending: Expected to be 5% of revenues, increasing investments for capacity expansion.
Cash Generation Guidance: Projected cash from operations between $10 million and $20 million.
Share Repurchase: In the first quarter, we purchased $5 million in shares.
Debt Reduction: We reduced our debt level by $15 million.
The earnings call highlights strong revenue growth, improved gross margins, and strategic expansion in specialty films, with optimistic guidance for MedTech and Precision Devices. While there are some uncertainties in M&A timelines and industrial segment growth, the overall sentiment remains positive due to high demand, operational improvements, and robust bookings. The Q&A session reinforced confidence in future growth and margin improvements, leading to a positive outlook for stock price movement.
The company reported strong financial performance with an 8% revenue increase and a 20% EPS rise. While SG&A expenses increased, the company maintained manageable debt levels and reduced interest expenses. Share repurchases of $30 million reflect confidence in cash flow. Positive guidance and strong bookings further support a positive outlook. Despite some margin pressures, the overall sentiment is positive, especially with expected margin improvements and continued revenue growth.
The earnings call reveals a mixed but generally positive outlook. Financial performance is stable with strong cash flow and debt reduction, despite slight revenue decline and margin pressure. Optimistic guidance for Q2 and beyond, along with strategic customer commitments, suggests future growth. Share repurchase and debt reduction enhance shareholder value. The Q&A indicates potential market share gains and improved margins. Tariff impacts are minimal, and customer demand remains solid. Overall, these factors suggest a potential positive stock price movement over the next two weeks.
The earnings call presents a mixed picture: strong cash flow and debt reduction are positives, but revenue and EPS are flat or slightly down YoY, with declining gross margins. The Q&A reveals management's cautious optimism about demand and gross margin improvement but also highlights production challenges and economic uncertainties. The share repurchase and debt reduction are positive, but the lack of clear guidance on market share gains and the impact of tariffs tempers enthusiasm. Overall, these factors suggest a neutral stock price reaction in the short term.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
